Personalis, Inc.

NASDAQ:PSNL

Medical - Diagnostics & Research

Healthcare
$14.98 +3.44%

+$0.34 today

Market cap
$1.62B
Beta
2.28
P/E (TTM)
-11.0
EPS (TTM)
-$0.92
52W Low $3.84High $12.53

Volume 1.47M

Average 2.31M

PSNL Net Margin

Net income as a percentage of revenue, showing how much of each sales dollar becomes profit.

Personalis, Inc.NASDAQ: PSNL

Net Margin · Q1 FY2026 · quarter ended Mar 2026

Net margin narrows to -194.1%

Net margin was -194.1% in Q1 FY2026, down 117.7 pp from a year earlier. On a trailing-twelve-month basis it was -148.1%, down 50.0 pp year over year.

Context

  • Net margin widened in 2 of the last 2 fiscal years.
  • FY2024 was the highest level in the 3 fiscal years shown.

What to watch

Whether next quarter's net margin reaches the consensus estimate of -169.2%, a -52.6 pp change from the same quarter last year.

Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.

Latest quarterMar 2026
-194.1%-56.8 pp QoQ
Last fiscal yearDec 2025
—— YoY
LTMMar 2026
-148.1%-50.0 pp YoY
Net Margin past and forecast change by horizon
Horizon Past Forecast Difference
Quarter-117.7 pp-52.6 pp+65.1 pp
1 year———
3 years———
5 years——
10 years——

Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.

Net Margin history

Percent of revenue · from the income statement

Latest · FY2024
-96.1%
Year-over-year change
+51.3pp
Reported Analyst consensus estimate Further estimates hidden. Sign in to unlock

Net Margin vs competitors

How PSNL compares with its peers on the latest reported figures

  • PSNL's LTM Mar 2026 net margin of -148.1% is the 9th highest of the 10 companies compared; the peer median is -23.0%.
  • Its year-over-year change of -50.0 pp is the lowest of 10, against a peer median of +6.3 pp.
PSNL Competitors Peer median
Net Margin for PSNL and competitors
Company Period LTM level YoY 3-year change
VCYTVeracyte, Inc.LTM Jun 202620.4% +14.9 pp+25.2 pp
BLLNBillionToOne, Inc.LTM Jun 20268.4% +23.1 pp—
NEONeoGenomics, Inc.LTM Jun 2026-6.8% +8.3 pp+13.4 pp
NTRANatera, Inc.LTM Jun 2026-7.1% +5.8 pp+57.8 pp
FLGTFulgent Genetics, Inc.LTM Mar 2026-23.0% -9.1 pp-41.9 pp
WGSGeneDx Holdings Corp.LTM Jun 2026-23.4% -23.8 pp+229.0 pp
GHGuardant Health, Inc.LTM Sep 2026-37.9% +6.3 pp+103.2 pp
MYGNMyriad Genetics, Inc.LTM Mar 2026-48.2% -36.0 pp-27.9 pp
PSNLPersonalis, Inc.LTM Mar 2026-148.1% -50.0 pp—
GRALGRAIL, Inc.LTM Jun 2026-236.9% +92.9 pp+9441.9 pp
Peer median (excluding PSNL) -23.0%+6.3 pp+41.5 pp

Competitors are the stored peer set for PSNL. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue85.49M65.05M73.48M84.61M0
Cost of Revenue53.84M51.7M55.27M57.79M53.87M
Gross Profit31.66M13.35M18.21M26.83M(53.87M)
Gross Margin37.0%20.5%24.8%31.7%—
Research & Development49.31M64.91M64.78M48.91M50.26M
Selling, General & Admin47.7M63.97M49.73M46.19M53.57M
Operating Expenses97.01M128.88M128.14M95.09M34.19M
Depreciation & Amortization6.01M8.43M11.3M10.94M10.05M
EBITDA(59.01M)(104.64M)(96.81M)(70.3M)(71M)
EBITDA Margin-69.0%-160.9%-131.7%-83.1%—
Operating Income(65.35M)(115.53M)(109.94M)(68.27M)(88.06M)
Operating Margin-76.4%-177.6%-149.6%-80.7%—
Interest Income367K2.4M5.9M5.51M7.16M
Interest Expense184K201K110K24K205K
Other Income / Expenses141K2.26M1.72M(13M)6.81M
Income Before Tax(65.21M)(113.28M)(108.21M)(81.27M)(81.25M)
Pre-Tax Margin-76.3%-174.1%-147.3%-96.0%—
Income Tax Expense14K40K83K18K21K
Net Income(65.23M)(113.32M)(108.3M)(81.28M)(81.27M)
Net Margin-76.3%-174.2%-147.4%-96.1%—
EPS (Basic)(1.49)(2.48)(2.25)(1.37)(0.91)
EPS (Diluted)(1.49)(2.48)(2.25)(1.37)(0.91)
Weighted Avg Shares43.89M45.7M48.18M59.25M89.24M
Weighted Avg Shares (Diluted)43.89M45.7M48.18M59.25M89.24M

Personalis, Inc.

NASDAQ:PSNL

Intrinsic Alpha fair value

Locked

Current Price

$14.98

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.